OSI Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of oncology, diabetes, and obesity in the United States. Its flagship product, Tarceva (erlotinib) is a small molecule inhibitor of the epidermal growth factor receptor. The company also offers Macugen for the treatment of neovascular age-related macular degeneration; and Novantrone, an anthracenedione used as an intravenous chemotherapy agent, as well as for the treatment of nonlymphocytic leukemia and the relief of pain associated with hormone refractory prostate cancer. Its products under development include OSI-930, a tyrosine...
read more
QUOTE
As of 05:14PM EDT May 26, 2012
$
( )
Today's Open:
Today's Close:
| Today's High: |
|
Volume (thous): |
|
| Today's Low: |
|
Avg Vol (thous): |
|
| 52 Week High: |
|
Bid (size): |
|
| 52 Week Low: |
|
Ask (size): |
|
COMPANY INFO
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer:
Company Details:
| Symbol: |
OSIP |
| SIC: |
-
|
| State location: |
NY |
| Sector: |
- |
| State of Inc: |
DE |
| Employees: |
491 |
| Type: |
NASDAQ |
OSI PHARM, INC (OSIP) MESSAGE BOARD
